Asset Details
Do you wish to reserve the book?
Mechanistic modeling as an explanatory tool for clinical treatment of chronic catatonia
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Mechanistic modeling as an explanatory tool for clinical treatment of chronic catatonia
Do you wish to request the book?
Mechanistic modeling as an explanatory tool for clinical treatment of chronic catatonia
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Mechanistic modeling as an explanatory tool for clinical treatment of chronic catatonia
2022
Overview
Mathematical modeling of neural systems is an effective means to integrate complex information about the brain into a numerical tool that can help explain observations. However, the use of neural models to inform clinical decisions has been limited. In this study, we use a simple model of brain circuitry, the Wilson-Cowan model, to predict changes in a clinical measure for catatonia, the Bush-Francis Catatonia Rating Scale, for use in clinical treatment of schizophrenia. This computational tool can then be used to better understand mechanisms of action for pharmaceutical treatments, and to fine-tune dosage in individual cases. We present the conditions of clinical care for a residential patient cohort, and describe methods for synthesizing data to demonstrated the functioning of the model. We then show that the model can be used to explain effect sizes of treatments and estimate outcomes for combinations of medications. We conclude with a demonstration of how this model could be personalized for individual patients to inform ongoing treatment protocols.
Publisher
Frontiers Media SA,Frontiers Media S.A
